Squarepoint
OPTN

Squarepoint’s OptiNose OPTN Stock Holding History

Squarepoint’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,517
Closed -$216K – 5380
2024
Q3 		$216K Buy
21,517
+10,076
+88% +$147K ﹤0.01% 3642
2024
Q2 		$178K Buy
11,441
+7,261
+174% +$122K ﹤0.01% 3689
2024
Q1 		$91.6K Buy
+4,180
New +$92.8K ﹤0.01% 3816
2022
Q4 		– Sell
-1,357
Closed -$75K – 3501
2022
Q3 		$75K Buy
+1,357
New +$74.5K ﹤0.01% 2825
2021
Q1 		– Sell
-3,311
Closed -$206K – 3483
2020
Q4 		$206K Sell
3,311
-2,012
-38% -$123K ﹤0.01% 2488
2020
Q3 		$311K Sell
5,323
-2,060
-28% -$153K ﹤0.01% 1766
2020
Q2 		$824K Buy
7,383
+5,410
+274% +$385K 0.01% 1050
2020
Q1 		$133K Sell
1,973
-2,486
-56% -$250K ﹤0.01% 1587
2019
Q4 		$617K Buy
4,459
+3,385
+315% +$439K ﹤0.01% 1639
2019
Q3 		$113K Buy
+1,074
New +$107K ﹤0.01% 2170

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Squarepoint's OPTN Position: Q4 2024 in Review

Squarepoint sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 21,517 shares — an estimated $216K sold.

Squarepoint first reported a position in OPTN in Q3 2019 and held it in 10 quarters. The position peaked at $824K in Q2 2020. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Squarepoint reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Squarepoint sold 21,517 OptiNose shares in Q4 2024, an estimated $216K.
  • Squarepoint first reported a position in OptiNose in Q3 2019 and held it in 10 quarters.
  • Squarepoint's OptiNose position peaked at $824K in Q2 2020.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.